MedLab / Pharmaceutical Market News
BD Announces $24 Million U.S. Government Investment to Support Scale Up of U.S. Manufacturing of COVID-19 Diagnostic Tests
Capital investments will enable U.S. manufacturing of 8 million BD Veritor™ brand SARS-CoV-2 tests per month
During the COVID-19 pandemic, we are working around the clock to meet the needs of healthcare providers so they can safely serve the patients who depend on them.
Beutlich® Pharmaceuticals, LLC has been offering healthcare professionals unique solutions for pain management and preventative care since 1954.
We are a family-owned business whose integrity our customers can count on. We will never cut corners to save money; we will give the best product to our customers in all situations. Our name on the label assures that quality.
Pioneering Microplate Technology for more than 50 Years
Before Northeastern professor James Benneyan described his research, he gave a stark reminder of the opioid epidemic it aims to address.
A pre-clinical study led by Indiana University scientists reports a promising step forward in the search for pain relief methods without the addictive side effects behind the country's current opioid addiction crisis.
(HealthDay)—More than half of Americans regularly take about four prescription medications, increasing the likelihood that mistakes could occur, according to Consumer Reports.
U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma.